Loading
Loading
Biomarin Pharmaceutical ceo salary
Alexander Hardy, President and CEO of BIOMARIN PHARMACEUTICAL INC (BMRN), received $21,927,563 ($21.9M) in total compensation for FY2025, up 47.6% from the prior year. Stock awards of $16,833,629 were the largest component. Figures come from BIOMARIN PHARMACEUTICAL INC's DEF 14A filed 21 Apr 2026 (accession 0001628280-26-026290).
Reported total from the latest DEF 14A pay table. Source filing (accession 0001628280-26-026290). These figures come from BIOMARIN PHARMACEUTICAL INC's DEF 14A filed 21 Apr 2026 (accession 0001628280-26-026290).
| Component | Amount |
|---|---|
| Salary | $1,130,769 |
| Stock awards | $16,833,629 |
| Option awards | $1,909,310 |
| Cash incentive | $1,644,500 |
| Other | $409,355 |
| Total | $21,927,563 |
FAQ
See also: BMRN ticker page